The surgery presents an exciting future that could bring relief for people who suffer from chronic lower back pain.

Completion of Recent Funding Round Allows Alopex to Expand Staff and Enhance Technology

US market share leader also launches HemoVue, an integrated cloud service that provides blood banks with streamlined management of devices and real-time operational visibility into all blood collection data.

A recent study published in the Journal of Wound Care (UK) has shed light on a revolutionary approach to diabetic foot care that promises hope and relief for millions worldwide.

Manuscript describes the unique character of a pancreatic endocrine cell population derived from a non-pluripotent stem cell that closely resembles native islets in composition and in vivo function.

Dr. William Rust, CEO of Seraxis, will deliver a lecture at the IPITA-IXA-CTRMS Joint Congress on October 29 at 10:00 a.m. in San Diego entitled “Novel stem cell-derived islet-like clusters potently control rodent blood glycemia”.

Seraxis will be taking meetings at BIO-Europe, November 6-8, in Munich.

The disposable insert makes loud flatulence nearly inaudible

Dr. William Rust will give an oral presentation on Seraxis’ proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as well as review initial diabetes model data of functional cure of Type 1 Diabetes. Seraxis’ presentation, entitled “Stem-cell Derived Islets for Treating Diabetes”, will be delivered in the session entitled "Transplantation of Islet and Stem Cells Today and Tomorrow".

Leadership team expanded with addition of Chief Corporate Development Officer, Ted Hibben, a 25-year venture-stage business development biotherapeutic industry veteran
Total venture funding tops $50M to date

Join Lyme Disease and Tick-Borne Illness Medical Experts In-Person

Now patients, caregivers and healthcare professionals have an easy and effective way to search and match to scleroderma clinical trials.

First Study of Its Kind Outlines Symptoms and Uncovers Proactive Steps Patients Can Take to Get Treatment

Unannounced Meal Management Efficacy Key to a Better Quality of Life for People with Diabetes

PureWay Compliance, Inc. provides safe sharps (needles, syringes, etc.) disposal to patients that self inject at home and do not wish to discard their needles in the trash. With increasing awareness of the hazards of dirty needles, patients are looking for safe and eco-friendly options to safely dispose of sharps at home. PureWay since 2013 has provided over 300,000 patients with sharps disposal by mail systems through strategic agreements with pharmaceutical manufacturers, non-profits like SafeNeedleDisposal and through stewardship programs.

Co-developing a dedicated smartphone app that controls the AID system. European market should be first to launch. Expanding product lineups and business.

Caution: The iLet Bionic Pancreas is an investigational device limited by Federal law to investigational use. Not available for sale.

Offer valid Nov. 1, 2022 - Nov. 30, 2022. While supplies last.

After developing severe esophagitis and being prescribed life-long medications, Jimmy Minhas, a doctor and founder of GerdLi, researched and created the world's first natural supplement to relieve heartburn and acid reflux.

4 million (1) hours of hypoglycemia avoided; Trust in the algorithm leads to fewer meal declarations; Users report a significantly reduced mental load

Ozempics Continuing to Stand Out as a New Type 2 Diabetes Medication Alternative

Noted Atlanta, Georgia, urgent care and primary care provider is emphasizing the benefits of in-depth, quality comprehensive chronic condition management.

August is Medical ID Awareness Month - that means savings & protection.

High-growth diabetes company Diabeloop closes its Series C financing round - led by LBO France, joined by Terumo Corporation, Innovacom and backed by Diabeloop's historical partners - to power the company's commercial roll-out and global expansion.

Confirmed Improvement in Time in Range +18.4 Percentage Points; Reduction of Time Spent in Hypoglycemia to Only 0.9%

Semaglutide Injection a 1x Weekly Option for Lowering Blood Glucose

Helmsley Charitable Trust Supports Effort to Strengthen Clinician Accountability

Happy Bob App offers Dexcom CGM users and their caregivers more ways to interact with their glucose data, including a real-time iOS widget, Apple Watch app, groups, gamification, and humorous personalized messages.

New Minnesota-Based Partnership Adds Comprehensive Obesity Management Platform to Clinic's Multi-Specialty Healthcare Offerings

Stem cell innovations aiming for the practical cure of type 1 diabetes, alopecia areata, and other autoimmune diseases

Paper Composed Collaboratively by Diabetes Expert Panel, Funded by Helmsley Charitable Trust

Owen Mumford's new one-of-a-kind home-use pen needle is designed to make the injection experience smooth from beginning to end.

ExpressionMed, who has been making designed medical tapes for over six years, is launching its biggest awareness campaign yet.

Access to More Affordable Medication Helps Those Sensitive to Rx Med Costs

After the success in Europe, the award-winning SNAQ App is now available for people living with diabetes in the United States. The app supports seamless integration with many popular glucose sensors and diabetes apps. Alongside this launch, Anton Kittelberger, Dr. David Kerr and John Sjolund are newly joining the Advisory Board of SNAQ.

Collective intelligence may hold the key to speeding up sickle cell research at the University of Pittsburgh

COMPANY LAUNCH: SageHome brings occupational therapists together with a professional installation team to simply and seamlessly create the ideal living space for recovery and wellness in the home.

A Free 14-day Online Summit Featuring 60 Speakers, Videos, Live Speaker Panels. Launches July 10th, Chronic Disease Awareness Day, through July 24th, 2020.

Jury finds punitive damages warranted against Boehringer Ingelheim Pharmaceuticals, Inc.

Support for 'In-Between Visit' Care Management for People with Behavioral Health Diagnoses, Developmental Disabilities and Drug Addiction

Anonymous donor presents $1 million gift to The Ehlers-Danlos Society to jumpstart groundbreaking genomic research into genetic cause of hypermobile Ehlers-Danlos syndrome (hEDS), a rare, degenerative, and all-too-often painful, disabling connective tissue disorder

New service for seniors will be led by Dr. Anna Monias.

Rapidly Growing Patient Populations and New Drug Classes are Key Drivers in this Market According to Greystone Research Associates